(
A) Growth of serial dilutions of wild type,
erd1, and
vps74 mutants on YPD with or without 60 µg/ml hygromycinB at the indicated temperature after 2 days. (
B) SAFE analysis of genetic interaction profiles of
erd1 and
vps74 mutant (cut-off (p < 3e-8)). (
C) Immunoblot analysis on yeast cell lysates from wild type,
mnn9,
och1,
ktr3,
kre2,
vps74 and
erd1 mutants for glycosylation reporter, Gas1. (
D) Growth of serial dilutions of wild type,
kre2,
ktr3,
kre2ktr3,
erd1 and
vps74 mutants on YPD with or without 60 µg/ml hygromycinB at 26° C after 2 days. (
E) Schematic depicting the known defects in the Vps74 mutants tested in
Figure 2H. (
F) Live-cell confocal fluorescence imaging of mNeonGreen-Vps74 along with early (Mnn9-mCherry), medial (Gea2-3xmMars), and late (Sec7-6xDsRed) Golgi markers. (
G) Violin plots for the ratio of co-localized mNeonGreen-Vps74 with the Golgi markers in (
F). Dashed lines indicate the median values, and dotted lines indicate the 95 CIs. Scale bars: 2.5µ m.